Obstructive sleep apnea treatment devices, systems and methods

USRE48024E · US · E1

Patent metadata
FieldValue
Publication numberUS-RE48024-E
Application numberUS-201514681764-A
CountryUS
Kind codeE1
Filing dateApr 8, 2015
Priority dateOct 13, 2006
Publication dateJun 2, 2020
Grant dateJun 2, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Devices, systems and methods for nerve stimulation for OSA therapy.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of treating obstructive sleep apnea, the method comprising: chronically implanting an electrode on a nerve innervating an upper airway dilator muscle; sensing a measure of respiration; analyzing the measure of respiration to identify onsets of expiration; calculating a respiratory period from the onsets of expiration; predicting the onset of a future expiratory phase; and beginning stimulation of the nerve a fraction of the calculated respiratory period before the onset of the future expiratory phase, and continuing stimulation of the nerve during an entire inspiratory phase, wherein the method is performed without identifying an onset of the inspiratory phase. 2. The method of claim 1 , wherein the fraction ranges between 30/100 and 50/100. 3. The method of claim 1 , wherein the fraction is selectively adjustable. 4. The method of claim 1 , wherein the measure of respiration is bio-impedance. 5. The method of claim 1 , wherein the electrode is disposed on a nerve cuff operably connected to a first end of a stimulation lead. 6. The method of claim 5 , wherein a second end of the stimulation lead is operably connected to a neurostimulator. 7. The method of claim 6 , wherein the neurostimulator is operably connected to a respiration sensing lead having a proximal end and a distal portion, wherein the distal portion is connected to a respiration sensor. 8. The method of claim 6 , wherein the neurostimulator includes electronics containing an algorithm. 9. The method of claim 8 , wherein the algorithm triggers the delivery of the stimulation via the stimulation lead. 10. The method of claim 5 , wherein the stimulation lead includes a sigmoid-shaped section. 11. The method of claim 5 , wherein the nerve cuff is cylindrical and includes a first semi-cylindrical portion connected to a second semi-cylindrical portion. 12. The method of claim 11 , wherein the first semi-cylindrical portion is shorter in length than the second semi-cylindrical portion. 13. The method of claim 5 , wherein the nerve cuff is cylindrical and includes a semi-cylindrical portion having a plurality of extending semi-cylindrical arms having free ends. 14. The method of claim 5 , wherein the nerve cuff includes a plurality of electrodes configured to steer an electrical field. 15. A method of treating obstructive sleep apnea, the method comprising: obtaining a respiration waveform; analyzing the respiration waveform to identify onsets of expiration; calculating a respiratory period from the onsets of expiration; predicting the onset of a future expiratory phase; and stimulating a nerve to cause dilation of a patient's upper airway, wherein stimulation of the nerve begins a fraction of the calculated respiratory period before the onset of the future expiratory phase, and continuing stimulation of the nerve during an entire inspiratory phase, wherein the method is performed without identifying an onset of the inspiratory phase. 16. The method of claim 15 , wherein the fraction is selectively adjustable. 17. The method of claim 15 , wherein analyzing the respiration waveform to identify onsets of expiration includes identifying a peak of the respiration waveform. 18. A method of treating obstructive sleep apnea with an electrode implanted on a nerve innervating an upper airway dilator muscle, the method comprising: sensing a measure of respiration to generate a respiration waveform; analyzing the respiration waveform to identify onsets of expiration; calculating a respiratory period from the onsets of expiration identified in the respiration waveform; and beginning stimulation of the nerve a fraction of the calculated respiratory period before an onset of a subsequent expiratory phase, and continuing stimulation of the nerve during an entire inspiratory phase, wherein the method is performed without identifying an onset of the inspiratory phase. 19. The method of claim 18, wherein the fraction ranges between 30/100 and 50/100. 20. The method of claim 18, wherein the fraction is selectively adjustable. 21. The method of claim 18, wherein the fraction of the calculated respiratory period is a predetermined amount of time. 22. The method of claim 18, wherein the measure of respiration is bio-impedance. 23. The method of claim 18, wherein the electrode is disposed on a nerve cuff operably connected to a first end of a stimulation lead including a first sigmoid section. 24. The method of claim 23, wherein the stimulation lead includes an anchor device disposed between the first sigmoid section and a second sigmoid section. 25. The method of claim 23, wherein a second end of the stimulation lead is operably connected to a neurostimulator. 26. The method of claim 25, wherein the neurostimulator is operably connected to a respiration sensing lead having a proximal end and a distal portion, wherein the distal portion is connected to a respiration sensor. 27. The method of claim 23, wherein the nerve cuff is cylindrical and includes a first semi-cylindrical portion connected to a second semi-cylindrical portion. 28. The method of claim 27, wherein the first semi-cylindrical portion is shorter in length than the second semi-cylindrical portion. 29. The method of claim 23, wherein the nerve cuff is cylindrical and includes a semi-cylindrical portion having a plurality of semi-cylindrical arms extending therefrom, the plurality of semi-cylindrical arms having free ends. 30. The method of claim 23, wherein the nerve cuff includes a plurality of electrodes configured to steer an electrical field. 31. The method of claim 18, wherein the onsets of expiration are identified without identifying an onset of an inspiratory phase. 32. A method of treating obstructive sleep apnea the method comprising: obtaining a respiration waveform; analyzing the respiration waveform to identify onsets of expiration; calculating a respiratory period from the identified onsets of expiration; stimulating a nerve to cause dilation of a patient's upper airway, wherein stimulation of the nerve begins a fraction of the calculated respiratory period before an onset of an expiratory phase; and continuing stimulation of the nerve during an entire inspiratory phase, wherein the step of stimulating the nerve is performed without identifying an onset of the inspiratory phase, and wherein the stimulation is delivered to the nerve via an electrode cuff positioned on the nerve and disposed on a distal end of a stimulation lead having a sigmoid section. 33. The method of claim 32, wherein analyzing the respiration waveform to identify onsets of expiration includes identifying a peak of the respiration waveform. 34. The method of claim 32, wherein the onsets of expiration are identified without identifying an onset of an inspiratory phase. 35. A method of treating obstructive sleep apnea using an electrode implanted on a nerve innervating an upper airway dilator muscle, the method comprising: sensing a biological parameter to generate a respiration waveform; analyzing the respiration waveform to identify at least a first onset of expiration and a second onset of expiration; calculating a respiratory period from the identified first and second onsets of expiration

Assignees

Inventors

Classifications

  • Human Necessities · mapped topic

  • Sleep apnoea · CPC title

  • A61N1/0556Primary

    Cuff electrodes · CPC title

  • Anchoring or fixation means therefor · CPC title

  • using differentiation including higher order derivatives · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent USRE48024E cover?
Devices, systems and methods for nerve stimulation for OSA therapy.
Who is the assignee on this patent?
Livanova Usa Inc
What technology area does this patent fall under?
Primary CPC classification A61N1/0556. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (E1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).